Term
|
Definition
Anxiolytic, Rarely Used anymore |
|
|
Term
|
Definition
Ultra-Short-Acting Barb, used in Induction of Anesthesia |
|
|
Term
|
Definition
Short-Acting Barb, Anxiolytic, Metabolism and Renal Excretion are Major Paths to terminate Drug Action |
|
|
Term
|
Definition
Depress Medullary Respiratory Center, Potentiated by Alcohol, Induces Enzymes altering self/non-self drug metabolism, Tolerance, Dependence (Severe Withdrawal) |
|
|
Term
|
Definition
Long T 1/2, Causes Skeletal Muscle Relaxation |
|
|
Term
|
Definition
Benzodiazepine with Intermediate Elimination (T 1/2) |
|
|
Term
|
Definition
Benzodiazepine with Intermediate Elimination (T 1/2) Does NOT require Phase 1 Metabolism therefore is safer in patients with hepatic failure |
|
|
Term
|
Definition
Benzo used to treat Panic Attacks |
|
|
Term
|
Definition
|
|
Term
|
Definition
Don't Cause Anesthesia, Less Severe Withdrawal, Can Cause both CNS Depression or paradoxical CNS Activation and nightmares, Tolerance and Dependance, Selflimited Action |
|
|
Term
|
Definition
@ high doses can directly activate Cl channels |
|
|
Term
|
Definition
Benzodiazepine Receptor Antagonist |
|
|
Term
Desmethydiazepam and Nordazepam |
|
Definition
|
|
Term
|
Definition
Slow Onset Anxiolytic with low addiction potential, Does not potentiate alcohol CNS Depression, Minimal Sedation, Stimulates 5-HT1a receptor (No action on GABA) |
|
|
Term
|
Definition
Hypnotic that Works @ Benzodiazepine Receptor, No rebound insomnia, No Withdrawal, Minimal Tolerance may occur |
|
|
Term
|
Definition
Mirrors Benzo Action by binding GABA Receptors at the same site BUT no tolerance for at least 6 months making this hypnotic useful for treating Chronic Insomnia |
|
|